{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:08:13Z","timestamp":1778810893451,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54MD007601"],"award-info":[{"award-number":["U54MD007601"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128080","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:05:39Z","timestamp":1765641939000},"page":"128080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Does changing the routinely recommended age for HPV vaccination change parental thoughts about vaccinating their adolescent: A mixed-methods analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Siobhan","family":"Coad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica J.","family":"Liebermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunjung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Zimet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly B.","family":"Fontenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2025.128080_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2530","article-title":"Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001\u20132017","volume":"5","author":"Liao","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.128080_bb0010","doi-asserted-by":"crossref","first-page":"708","DOI":"10.15585\/mmwr.mm7333a1","article-title":"National vaccination coverage among adolescents aged 13\u201317 years\u2014National Immunization Survey-Teen, United States, 2023","volume":"73","author":"Pingali","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128080_bb0015","unstructured":"Centers for Disease Control and Prevention. HPV vaccination recommendations. Centers for Disease Control and Prevention. November 2021. https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/recommendations.html."},{"issue":"4","key":"10.1016\/j.vaccine.2025.128080_bb0020","first-page":"274","article-title":"Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation","volume":"70","author":"Saslow","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2025.128080_bb0025","unstructured":"American Cancer Society's National HPV Vaccination Roundtable. 2023 National Age 9 CTA Letter [Letter]. March 20, 2023. https:\/\/hpvroundtable.org\/wp-content\/uploads\/2023\/05\/2023-National-Age-9-CTA-Letter-Final.pdf."},{"issue":"6","key":"10.1016\/j.vaccine.2025.128080_bb0030","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2146434","article-title":"Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9","volume":"18","author":"O\u2019Leary","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128080_bb0035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-058794","article-title":"Early initiation of HPV vaccination and series completion in early and mid-adolescence","volume":"151","author":"Goodman","year":"2023","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128080_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2175555","article-title":"The association of initiating HPV vaccination at ages 9-10 and up-to-date status among adolescents ages 13-17 years, 2016-2020","volume":"19","author":"Minihan","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128080_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2180971","article-title":"Does HPV vaccination initiation at age 9 improve HPV initiation and vaccine series completion rates by age 13?","volume":"19","author":"O\u2019Leary","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128080_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2161253","article-title":"HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US","volume":"19","author":"Saxena","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128080_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ypmed.2016.02.039","article-title":"Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion","volume":"89","author":"Sauver","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2025.128080_bb0060","unstructured":"American Cancer Society's National HPV Vaccination Roundtable. 2023 National Age 9 CTA Letter. March 20, 2023. Accessed November 13, 2025. https:\/\/hpvroundtable.org\/wp-content\/uploads\/2023\/05\/2023-National-Age-9-CTA-Letter-Final.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2025.128080_bb0065","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1055-9965.EPI-18-0885","article-title":"Trends in human papillomavirus vaccine types 16 and 18 in cervical precancers, 2008-2014","volume":"28","author":"McClung","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2025.128080_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7406a4","article-title":"Trends in cervical precancers identified through population-based surveillance \u2014 human papillomavirus vaccine impact monitoring project, five sites, United States, 2008\u20132022","volume":"74","author":"Gargano","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128080_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the Quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128080_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2907","article-title":"Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045","volume":"7","author":"Zhang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.vaccine.2025.128080_bb0085","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jadohealth.2025.05.003","article-title":"Early adolescent immunization schedule preferences: US national online survey of parents of children aged 9-10 years","volume":"77","author":"Zimet","year":"2025","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2025.128080_bb0090","unstructured":"R Core Team. R: A language and environment for statistical computing. Version 4.5.1. R Foundation for Statistical Computing; 2025. Accessed November 11, 2025. https:\/\/www.R-project.org\/."},{"issue":"6","key":"10.1016\/j.vaccine.2025.128080_bb0095","article-title":"Trends in reasons for human papillomavirus vaccine hesitancy: 2010\u20132020","volume":"151","author":"Boakye","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.128080_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ypmed.2017.07.016","article-title":"Association of physicians\u2019 perceived barriers with human papillomavirus vaccination initiation","volume":"105","author":"Farias","year":"2017","journal-title":"Prev Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128080_bb0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.vaccine.2019.01.051","article-title":"Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention","volume":"37","author":"Dempsey","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128080_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pedn.2018.10.006","article-title":"Effective HPV vaccination strategies: what does the evidence say? An integrated literature review","volume":"44","author":"Holloway","year":"2019","journal-title":"J Pediatr Nurs"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128080_bb0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.acap.2022.01.008","article-title":"Recommending human papillomavirus vaccination at age 9: a national survey of primary care professionals","volume":"22","author":"Kong","year":"2022","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.vaccine.2025.128080_bb0120","year":"2024","journal-title":"Centers for Disease Control and Prevention. May 2024"},{"key":"10.1016\/j.vaccine.2025.128080_bb0125","unstructured":"Office of Disease Prevention and Health Promotion. Increase the proportion of adolescents who get recommended doses of the HPV vaccine \u2014 IID-08. Healthy People 2030. U.S. Department of Health and Human Services. Updated July 30, 2024. Accessed August 4, 2025. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/vaccination\/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:58:30Z","timestamp":1773827910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"alternative-id":["S0264410X25013787"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does changing the routinely recommended age for HPV vaccination change parental thoughts about vaccinating their adolescent: A mixed-methods analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128080"}}